NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action
about
Lipocalin 13 regulation of glucose and lipid metabolism in obesityEnergy metabolism in the liverRegulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsMouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis.Insulin resistance in Alzheimer's disease.Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in miceCarboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injuryNuclear factor κB-inducing kinase activation as a mechanism of pancreatic β cell failure in obesity.Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA PathwayHepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesityRORα switches transcriptional mode of ERRγ that results in transcriptional repression of CYP2E1 under ethanol-exposure.Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signallingIntracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in miceLncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL).TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney DiseaseLiver NF-κB-inducing Kinase (NIK) Promotes Liver Steatosis and Glucose Counterregulation in Male Mice with Obesity.Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.The non-canonical NF-κB pathway in immunity and inflammation.Nigella sativa Oil and Chromium Picolinate Ameliorate Fructose-Induced Hyperinsulinemia by Enhancing Insulin Signaling and Suppressing Insulin-Degrading Enzyme in Male Rats.Constitutive expression of NF-κB inducing kinase in regulatory T cells impairs suppressive function and promotes instability and pro-inflammatory cytokine production.High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.Mildly compromised tetrahydrobiopterin cofactor biosynthesis due to Pts variants leads to unusual body fat distribution and abdominal obesity in mice.Midgut-Derived Activin Regulates Glucagon-like Action in the Fat Body and Glycemic Control.Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseasesEr-Miao-Fang Extracts Inhibits Adipose Lipolysis and Reduces Hepatic Gluconeogenesis via Suppression of Inflammation
P2860
Q26996675-F336C1EF-3ED8-4433-8170-B602FF868AA5Q26996783-F8512614-0503-4B0D-828A-90782837BC8CQ28537971-3802556E-3708-41E4-9CDA-F13C9012E3C4Q30239808-6549EA59-996B-468E-A9C9-F300237A9DBCQ34577231-F02B9E19-14D2-40A6-9A63-228222C3C7D4Q34622157-FD2B48FB-256C-4FE3-A45F-4639CD45ABC4Q35073042-9BF7B816-FE18-42FE-8EF6-AD773111C0AFQ35561105-A80C3288-3325-4BD4-AEBB-300DC1D1998DQ35894344-08ABD37A-7E2B-43A3-9611-1EB31D2508EDQ36104639-B34FDAB2-A6CB-42DD-AAEE-7442A0FEBC6AQ36516925-275FA1EE-53B6-4376-B81F-AE800D0B92F4Q36588873-5CFBFF79-2128-44C2-ACDF-006A4E719A30Q36591276-6D79FB56-A288-499D-8EAE-E2115C51E949Q37341960-57AA4D0E-7D8F-411E-B975-1E7301B7341CQ37348806-E5CCFAD7-9CB4-49A2-BE1D-1243249D5C1CQ38171480-E16BEBF1-566F-40F2-8288-FA0CF82B2871Q38853284-A9AD6C4B-62D2-41CB-A796-A749A2BE7EA1Q39197051-96678515-59DD-4A9D-9E03-5EADAB87B41CQ39350735-D5762390-36ED-480B-8B50-49254E9AB696Q46612188-D3A603AE-4312-493C-A3D8-1C88017BD49EQ47094157-32AA133B-8C9B-47C0-A016-9680225F2F07Q47389741-83A84AA8-2569-418A-9390-355733598E4AQ48938000-0DA31352-2927-4AA1-9190-4F909AD8128BQ49727393-B668D54A-F647-40E9-AB5C-EDD853EF9339Q56530561-53061A6D-A963-497A-9532-82D18A1B6777Q58781403-DDEB2861-5FAB-4A01-88C4-E335B0322C29
P2860
NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NF-κB–inducing kinase (NIK) pr ...... by augmenting glucagon action
@en
NF-κB–inducing kinase
@nl
type
label
NF-κB–inducing kinase (NIK) pr ...... by augmenting glucagon action
@en
NF-κB–inducing kinase
@nl
prefLabel
NF-κB–inducing kinase (NIK) pr ...... by augmenting glucagon action
@en
NF-κB–inducing kinase
@nl
P2093
P2860
P921
P356
P1433
P1476
NF-κB–inducing kinase (NIK) pr ...... by augmenting glucagon action
@en
P2093
Decheng Ren
Kae Won Cho
Liang Sheng
Liangyou Rui
Yingjiang Zhou
Yoshiteru Sasaki
P2860
P2888
P304
P356
10.1038/NM.2756
P407
P577
2012-06-01T00:00:00Z